Antibody

© Getty Images

Epsilogen completes first-ever IgE antibody clinical trial

By Isabel Cameron

Epsilogen, a leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, has published phase 1 data from the first ever clinical trial of an IgE antibody therapeutic in Nature Communications.

Pic:getty/libredroit

Genmab expands immunology reach in argenx pact

By Jonathan Smith

In a move to increase its presence in immunology and inflammation, the Danish biotech Genmab has launched a collaboration with argenx in the Netherlands to co-discover and co-develop antibody treatments.

Pic:getty/kojofeja

BigHat Biosciences enters AI research collaboration with Merck

By Rachel Arthur

BigHat Biosciences, a US biotech with a machine learning-guided antibody discovery and development platform, has announced a collaboration with Merck to apply its technology to design candidates for up to three drug discovery programs.

Pic:getty/dzmitrydzemidovich

Long-COVID personalized medicine enters Phase 2 trial

By Rachel Arthur

GeNeuro has recruited the first patients in a Phase 2 trial evaluating temelimab against long-COVID: assessing the efficacy of the treatment for improving cognitive impairment and fatigue.

© GettyImages/Artur

NPD Gallery: Technology Insider

By Jane Byrne

We track developments and launches in process engineering tools and research components over the past few weeks.

Pic:getty/blackdovfx

AION Labs spots 'unique opportunity' for AI-driven antibody discovery

By Rachel Arthur

AION Labs, a new innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, has announced a global call for application to identify biomedical scientists and inventors to form a new startup at...

© GettyImages/Shutter2U

Special Edition: The Future of Continuous BioProcessing

Addressing barriers to the shift to downstream continuous processing

By Nick Taylor

The shift away from batch downstream processing has moved closer in recent years amid progress on techniques such as antibody purification using continuous chromatography media. However, there remain barriers to clear before manufacturing facilities that...

© GettyImages/ipopba

Study: Early test and treat is vital in people infected with COVID-19

By Jane Byrne

A new mathematical modeling study by Ashish Goyal and colleagues, informed by data collected from 25 patients hospitalized with COVID-19 in four different countries, offers some important new insights into the optimal timing of four different antiviral...